Korea's Stroke Deaths Fell 82%. A Nature Study Says That Bought 3.6 Years of Life.

Last month a study in Nature asked the question most longevity coverage skips. Not whether Koreans live longer — which deaths stopped happening. Then it put a number of years on each one. For Korea the biggest answer was stroke: about 3.59 years of added life expectancy, roughly 30% of the country's 11.7-year gain since 1990. More than three times the next cause on the list.

What Korea did about it

Blood pressure, mostly — the largest treatable cause of stroke. In 1998 about 5% of Korean adults with hypertension had it controlled under 140/90. By 2023 it was 62%. Koreans filling blood-pressure prescriptions for at least 290 days a year went from 0.61 million in 2002 to 8.3 million in 2023.

The step a decomposition cannot show

A decomposition tells you that deaths fell as blood pressure came down. It cannot tell you how those people got onto treatment — and that step is not automatic. Nobody takes a pill for a number nobody ever measured. High blood pressure has no symptoms. It sends no one to a doctor. It has to be found first.

Korea found it by measuring almost everybody, on a schedule. The national screening program covered 23.2 million eligible adults in 2024, and 17.5 million took it — 75.6%. Office workers every two years, non-office workers every year, a blood pressure reading at every one of those visits. And easy access to clinics and specialists made it possible to get additional measurements whenever needed. My mother had high blood pressure, and my own readings often come back above 130 during checkups. On the advice of a family medicine doctor at a screening center, I bought a home blood pressure monitor. It has become one of the health measurements I check most often.

The result shows up in who knows. 79% of Koreans with hypertension are aware of it. In the United States, 59.2%. Those two are not measured identically — the US counts hypertension from the lower threshold of 130/80, pulling milder cases into the denominator and dragging its rate down — so the gap is not as clean as 79 versus 59. The direction is not in dispute.

What this means for your checkup

A checkup does the finding well — the blood pressure, cholesterol and glucose that produce no symptoms until they produce a stroke. That is most of what we sell.

But 3.59 years was not bought by an appointment. It was bought by twenty years of people taking a pill almost every day. A checkup in Seoul cannot do that part; your own doctor at home, over years, can. Finding the number is the easy half, and the easy half is the half we sell. So read the boring page of your results sheet as carefully as the scan report.

Take control of your health. Build your checkup in minutes. We'll handle the clinic, the booking and the logistics. Build my checkup.

About the Author

Donkyo Seo
Co-founder & CEO, Himedi

For the past 9 years, Donkyo has helped international patients navigate Korean healthcare. Himedi is licensed by Korea's Ministry of Health & Welfare (License #A-2016-01-01-2345). 

Sources

Verified directly:

• Kang J, et al. "Mapping drivers of life expectancy change in Asia from 1990 to 2023." Nature, July 22, 2026. doi:10.1038/s41586-026-10739-6 — 34 Asian countries and territories, 1990–2023, Global Burden of Disease 2023. Corresponding author: Yon Dong-keon, Kyung Hee University College of Medicine. Subscription access; a Nature Research Briefing accompanies it (doi:10.1038/d41586-026-02166-4)
• Statistics Korea / National Data Office, Cause of Death Statistics — KOSIS table DT_1B34E12, age-standardised death rates by cause (104 items), 1996– . Cerebrovascular disease, ICD-10 I60–I69, whole country, both sexes: 104.4 per 100,000 in 1996 → 18.9 in 2024 (2006: 59.0; 2015: 29.2; 2022: 21.3). Retrieved August 22, 2026. Statistics Korea notes the series was back-corrected for 1983–2007 to unify sources and tabulation methods, so it differs from figures published at the time
• Korean Society of Hypertension, Korea Hypertension Fact Sheet 2025 — KNHANES 1998–2023 and National Health Insurance claims 2002–2023, adults 20+. Control rate among all people with hypertension 62% in 2023; awareness 79%. Continuous treatment, defined as antihypertensive medication prescribed 290 days or more in the year, 0.61M (2002) → 8.32M (2023)
• Kim HC, et al. "Prevalence, Awareness, Treatment, and Control of Hypertension in Korea." Scientific Reports 2019 — 1998 control rate 4.9%, adults 30+, same <140/90 definition
• National Health Insurance Service, 2024 Health Screening Statistical Yearbook (press release, December 30, 2025) — general health screening 2024: 23,181,731 eligible, 17,517,365 screened, participation 75.6%. Every two years for office workers, regional-subscriber householders, adults 20+ and dependants; annually for non-office workers. Blood pressure measurement included
• Fryar CD, et al. "Hypertension Prevalence, Awareness, Treatment, and Control Among Adults Age 18 and Older: United States, August 2021–August 2023." NCHS Data Brief No. 511 — aware 59.2%, treated 51.2%, controlled 20.7%. US hypertension defined as ≥130/80 mmHg or taking medication. This threshold differs from Korea's ≥140/90; the rates are not directly comparable

Relayed from press coverage of the Nature paper, not verified against the article itself:

• Korea's life expectancy 71.7 (1990) → 83.4 (2023); stroke contributing 3.586 years, about 30% of the gain; the ranked list of other causes — as reported by Chosun Ilbo and Seoul Shinmun, July 23–24, 2026
• The Lancet Public Health, GBD 2023 morbidity-gap analysis, July 2026 — years lived in poor health in Korea, 9.4 (1990) → 11.6 (2023), as reported in the same coverage